No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Eli Lilly in Talks to Acquire Scorpion Therapeutics, FT Says; Relay Therapeutics Surges
Relay Therapeutics Shares Resume Trade Following Circuit Breaker Halt
Trade Alert: Chief Corporate Development Officer Of Relay Therapeutics Peter Rahmer Has Sold Stock
Relay Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
Is Relay Therapeutics (RLAY) the Best Biotech Penny Stock to Invest in Now?
We Think Relay Therapeutics (NASDAQ:RLAY) Needs To Drive Business Growth Carefully